Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 361

1.

The mucin profile of noninvasive and invasive mucinous cystic neoplasms of the pancreas.

Lüttges J, Feyerabend B, Buchelt T, Pacena M, Klöppel G.

Am J Surg Pathol. 2002 Apr;26(4):466-71.

PMID:
11914624
2.

Expression of mucins (MUC1, MUC2, MUC5AC and MUC6) in mucinous carcinoma of the breast: comparison with invasive ductal carcinoma.

Matsukita S, Nomoto M, Kitajima S, Tanaka S, Goto M, Irimura T, Kim YS, Sato E, Yonezawa S.

Histopathology. 2003 Jan;42(1):26-36.

PMID:
12493022
3.

MUC1 overexpression is the most reliable marker of invasive carcinoma in intraductal papillary-mucinous tumor (IPMT).

Ueda M, Miura Y, Kunihiro O, Ishikawa T, Ichikawa Y, Endo I, Sekido H, Togo S, Shimada H.

Hepatogastroenterology. 2005 Mar-Apr;52(62):398-403.

PMID:
15816444
5.

Mucin gene expression in intraductal papillary-mucinous pancreatic tumours and related lesions.

Terris B, Dubois S, Buisine MP, Sauvanet A, Ruszniewski P, Aubert JP, Porchet N, Couvelard A, Degott C, Fléjou JF.

J Pathol. 2002 Aug;197(5):632-7.

PMID:
12210083
6.

The expression of several types of mucin is related to the biological behavior of pancreatic neoplasms.

Yonezawa S, Nakamura A, Horinouchi M, Sato E.

J Hepatobiliary Pancreat Surg. 2002;9(3):328-41.

PMID:
12353144
7.

Expression of mucin antigens in human cancers and its relationship with malignancy potential.

Yonezawa S, Sato E.

Pathol Int. 1997 Dec;47(12):813-30. Review.

PMID:
9503463
8.

The dichotomy in the preinvasive neoplasia to invasive carcinoma sequence in the pancreas: differential expression of MUC1 and MUC2 supports the existence of two separate pathways of carcinogenesis.

Adsay NV, Merati K, Andea A, Sarkar F, Hruban RH, Wilentz RE, Goggins M, Iocobuzio-Donahue C, Longnecker DS, Klimstra DS.

Mod Pathol. 2002 Oct;15(10):1087-95.

9.

Mucin expression profile is related to biological and clinical characteristics of intraductal papillary-mucinous tumors of the pancreas.

Ito H, Endo T, Oka T, Matumoto T, Abe T, Toyota M, Imai K, Satoh M, Maguchi H, Shinohara T.

Pancreas. 2005 May;30(4):e96-102.

PMID:
15841035
10.

Dpc4 protein in mucinous cystic neoplasms of the pancreas: frequent loss of expression in invasive carcinomas suggests a role in genetic progression.

Iacobuzio-Donahue CA, Wilentz RE, Argani P, Yeo CJ, Cameron JL, Kern SE, Hruban RH.

Am J Surg Pathol. 2000 Nov;24(11):1544-8.

PMID:
11075857
11.

Diagnostic utility of mucin profile in fine-needle aspiration specimens of the pancreas: an immunohistochemical study with surgical pathology correlation.

Giorgadze TA, Peterman H, Baloch ZW, Furth EE, Pasha T, Shiina N, Zhang PJ, Gupta PK.

Cancer. 2006 Jun 25;108(3):186-97.

13.

Intestinal metaplasia of human stomach displays distinct patterns of mucin (MUC1, MUC2, MUC5AC, and MUC6) expression.

Reis CA, David L, Correa P, Carneiro F, de Bolós C, Garcia E, Mandel U, Clausen H, Sobrinho-Simões M.

Cancer Res. 1999 Mar 1;59(5):1003-7.

14.

Comparison between mucinous cystic neoplasm and intraductal papillary mucinous neoplasm of the branch duct type of the pancreas with respect to expression of CD10 and cytokeratin 20.

Nishigami T, Onodera M, Torii I, Sato A, Tao LH, Kushima R, Kakuno A, Kishimoto M, Katsuyama E, Fujimori T, Hirano H, Satake M, Kuroda N, Nishiguchi S, Fujimoto J, Tsujimura T.

Pancreas. 2009 Jul;38(5):558-64. doi: 10.1097/MPA.0b013e31819f3bd6.

PMID:
19287335
15.

Expression of mucins (MUC1, MUC2, MUC3, MUC4, MUC5AC and MUC6) and their prognostic significance in human breast cancer.

Rakha EA, Boyce RW, Abd El-Rehim D, Kurien T, Green AR, Paish EC, Robertson JF, Ellis IO.

Mod Pathol. 2005 Oct;18(10):1295-304.

16.

Intraductal tubular adenoma of the pancreas, pyloric gland type: a clinicopathologic and immunohistochemical study of 6 cases.

Nakayama Y, Inoue H, Hamada Y, Takeshita M, Iwasaki H, Maeshiro K, Iwanaga S, Tani H, Ryu S, Yasunami Y, Ikeda S.

Am J Surg Pathol. 2005 May;29(5):607-16.

PMID:
15832084
17.

Gene expression of gastric type mucin (MUC5AC) in pancreatic tumors: its relationship with the biological behavior of the tumor.

Yonezawa S, Horinouchi M, Osako M, Kubo M, Takao S, Arimura Y, Nagata K, Tanaka S, Sakoda K, Aikou T, Sato E.

Pathol Int. 1999 Jan;49(1):45-54.

PMID:
10227724
18.

MUC1, MUC2, MUC5AC, and MUC6 expressions in gastric carcinomas: their roles as prognostic indicators.

Lee HS, Lee HK, Kim HS, Yang HK, Kim YI, Kim WH.

Cancer. 2001 Sep 15;92(6):1427-34.

PMID:
11745219
19.

Aberrant expression of MUC5AC and MUC6 gastric mucins and sialyl Tn antigen in intraepithelial neoplasms of the pancreas.

Kim GE, Bae HI, Park HU, Kuan SF, Crawley SC, Ho JJ, Kim YS.

Gastroenterology. 2002 Oct;123(4):1052-60.

PMID:
12360467
20.

Differential roles of alterations of p53, p16, and SMAD4 expression in the progression of intraductal papillary-mucinous tumors of the pancreas.

Sasaki S, Yamamoto H, Kaneto H, Ozeki I, Adachi Y, Takagi H, Matsumoto T, Itoh H, Nagakawa T, Miyakawa H, Muraoka S, Fujinaga A, Suga T, Satoh M, Itoh F, Endo T, Imai K.

Oncol Rep. 2003 Jan-Feb;10(1):21-5.

PMID:
12469138

Supplemental Content

Support Center